Comments on: Why Bio/Pharma Should Open Up

By: Data, not in papers at Bench Press

Data, not in papers at Bench Press — Wed, 07 Jul 2010 07:01:53 +0000

[...] I think they both have a very good point. Some form of centralized data repository, even if non-peer reviewed, could help tackle the problem that everyone hears about but nobody ever tries to solve of not having a central place to share negative results and protocols (akin to what this blog proposed previously for bio/pharma companies). [...]

By: Russia dreams of Silicon Valley sheep

Russia dreams of Silicon Valley sheep — Mon, 22 Mar 2010 13:05:33 +0000

[...] Five-Year Plans) than it is for an authoritarian regime to encourage the trial & error, open exchange of ideas, and “disorganized” development which is necessary to drive innovative technology disruptions [...]

By: GSK Opens Up on Malaria at Bench Press

GSK Opens Up on Malaria at Bench Press — Mon, 22 Feb 2010 13:01:38 +0000

[...] few weeks ago, we posted a number of reasons why we believe the Pharmaceutical industry needs to pursue greater openness to accelerate innovation and reduce the cost and time of drug development. A few weeks after that, [...]